About InfuSystem Holdings (NYSEAMERICAN:INFU)
InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.
Industry, Sector and Symbol:
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Sector: Medical Equipment, Supplies & Distribution - NEC
- Symbol: NYSEAMERICAN:INFU
- Previous Symbol: NYSE:INFU
- CUSIP: N/A
- Web: ir.infusystem.com
- Trailing EPS: ($0.14)
- Net Margins: -6.53%
- Return on Equity: -9.02%
- Return on Assets: -4.91%
- Outstanding Shares: 22,780,000
Frequently Asked Questions for InfuSystem Holdings (NYSEAMERICAN:INFU)
What is InfuSystem Holdings' stock symbol?
InfuSystem Holdings trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How were InfuSystem Holdings' earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) issued its quarterly earnings data on Monday, December, 12th. The medical instruments supplier reported $0.00 EPS for the quarter. The medical instruments supplier had revenue of $17.23 million for the quarter. InfuSystem Holdings had a negative return on equity of 9.02% and a negative net margin of 6.53%. View InfuSystem Holdings' Earnings History.
Who are some of InfuSystem Holdings' key competitors?
Some companies that are related to InfuSystem Holdings include Bioquell plc (BQE), Tandem Diabetes Care (TNDM), Surgical Innovations Group plc (SUN), Capnia (SLNO), Cytori Therapeutics (CYTX), Alliqua BioMedical (ALQA), NeuroMetrix (NURO), InspireMD (NSPR), Great Basin Scientific (GBSN), Asante Solutions (PUMP), LDR Holding Corp (LDRH) and Symmetry Medical (SMA).
Who are InfuSystem Holdings' key executives?
InfuSystem Holdings' management team includes the folowing people:
- Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
- Richard Diiorio, President, Chief Executive Officer, Director
- Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
- Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
- Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
- Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
- Darrell B. Montgomery, Director (Age 55)
- Ryan J. Morris, Director (Age 32)
- Christopher R. Sansone, Director
- Scott A. Shuda, Director (Age 50)
How do I buy InfuSystem Holdings stock?
Shares of InfuSystem Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem Holdings' stock price today?
One share of InfuSystem Holdings stock can currently be purchased for approximately $2.10.
How big of a company is InfuSystem Holdings?
InfuSystem Holdings has a market capitalization of $51.52 million.
How can I contact InfuSystem Holdings?
InfuSystem Holdings' mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem Holdings (NYSEAMERICAN INFU)MarketBeat's community ratings are surveys of what our community members think about InfuSystem Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for InfuSystem Holdings (NYSEAMERICAN:INFU) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for InfuSystem Holdings (NYSEAMERICAN:INFU)
Analysts' Ratings History for InfuSystem Holdings (NYSEAMERICAN:INFU)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for InfuSystem Holdings (NYSEAMERICAN:INFU)
Earnings History by Quarter for InfuSystem Holdings (NYSEAMERICAN INFU)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/9/2017||Q2 2017||($0.02)||$16.94 million||View||Listen|
|3/22/2017||Q4 2016||$0.07||($0.01)||$16.85 million||View||N/A|
|12/12/2016||Q3 2016||$0.00||$17.23 million||View||N/A|
|8/10/2016||Q216||$0.04||$17.20 million||$19.10 million||View||Listen|
|5/10/2016||Q116||$0.02||$16.70 million||$19.00 million||View||N/A|
|5/12/2015||Q115||$0.06||$0.03||$17.20 million||$16.70 million||View||Listen|
|3/9/2015||Q414||$0.05||$0.05||$17.20 million||$16.20 million||View||N/A|
|11/10/2014||Q3 2014||$0.05||$0.04||$16.61 million||View||N/A|
|8/1/2014||Q2 2014||$0.04||$16.37 million||View||N/A|
|5/5/2014||Q1 2014||$0.03||$0.03||$17.24 million||View||N/A|
Earnings Estimates for InfuSystem Holdings (NYSEAMERICAN:INFU)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for InfuSystem Holdings (NYSEAMERICAN:INFU)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for InfuSystem Holdings (NYSEAMERICAN INFU)
Insider Trades by Quarter for InfuSystem Holdings (NYSEAMERICAN INFU)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/11/2017||Meridian Ohc Partners, Lp||Director||Buy||19,982||$2.00||$39,964.00|| |
|8/30/2017||Meridian Ohc Partners, Lp||Director||Buy||30,900||$1.90||$58,710.00|| |
|8/28/2017||Meridian Ohc Partners, Lp||Director||Buy||30,000||$1.90||$57,000.00|| |
|8/25/2017||Meridian Ohc Partners, Lp||Director||Buy||13,381||$1.84||$24,621.04|| |
|8/24/2017||Meridian Ohc Partners, Lp||Director||Buy||155||$1.80||$279.00|| |
|8/23/2017||Meridian Ohc Partners, Lp||Director||Buy||2,166||$1.80||$3,898.80|| |
|8/16/2017||Meridian Ohc Partners, Lp||Director||Buy||56,670||$1.84||$104,272.80|| |
|8/15/2017||Richard Dilorio||Director||Buy||4,875||$1.95||$9,506.25|| |
|8/14/2017||Christopher Downs||CFO||Buy||7,900||$1.90||$15,010.00|| |
|8/14/2017||Darrell B Montgomery||Director||Buy||25,000||$1.88||$47,000.00|| |
|6/7/2017||Meridian Ohc Partners, Lp||Director||Buy||10,109||$1.55||$15,668.95|| |
|6/2/2017||Meridian Ohc Partners, Lp||Director||Buy||10,100||$1.55||$15,655.00|| |
|5/25/2017||Meridian Ohc Partners, Lp||Director||Buy||6,105||$1.55||$9,462.75|| |
|5/19/2017||Ryan J Morris||Director||Buy||15,000||$1.28||$19,200.00|| |
|5/17/2017||Ryan J Morris||Director||Buy||29,614||$1.45||$42,940.30|| |
|3/27/2017||Ryan J Morris||Director||Buy||21,651||$2.20||$47,632.20|| |
|3/24/2017||Ryan J Morris||Director||Buy||94,200||$2.14||$201,588.00|| |
|12/19/2016||Eric K. Steen||Insider||Buy||12,000||$2.33||$27,960.00|| |
|12/16/2016||Meridian Ohc Partners, Lp||Director||Buy||200,000||$2.34||$468,000.00|| |
|9/14/2016||Ryan J Morris||Director||Buy||23,171||$2.85||$66,037.35|| |
|9/13/2016||Ryan J Morris||Director||Buy||16,829||$2.88||$48,467.52|| |
|9/8/2016||Ryan J Morris||Director||Buy||17,171||$2.84||$48,765.64|| |
|9/2/2016||Ryan J Morris||Director||Buy||4,600||$2.84||$13,064.00|| |
|11/19/2015||Eric K. Steen||CEO||Buy||2,461||$2.88||$7,087.68|| |
|11/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||29,600||$2.82||$83,472.00|| |
|11/3/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,689||$2.75||$21,144.75|| |
|10/28/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||17,100||$2.71||$46,341.00|| |
|10/13/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||14,290||$2.82||$40,297.80|| |
|10/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||1,860||$2.83||$5,263.80|| |
|8/24/2015||Eric K. Steen||CEO||Buy||5,000||$2.83||$14,150.00|| |
|8/19/2015||Eric K. Steen||CEO||Buy||7,360||$2.92||$21,491.20|| |
|8/18/2015||Jonathan P Foster||CFO||Buy||1,000||$2.92||$2,920.00|| |
|6/23/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,500||$3.19||$23,925.00|| |
|6/15/2015||Gregg Owen Lehman||Director||Buy||2,000||$3.23||$6,460.00|| |
|6/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||12,786||$3.16||$40,403.76|| |
|6/8/2015||Gregg Owen Lehman||Director||Buy||18,000||$3.19||$57,420.00|| |
|6/4/2015||David C Dreyer||Director||Sell||10,000||$3.15||$31,500.00|| |
|6/4/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||19,550||$3.15||$61,582.50|| |
|5/19/2015||Eric K Steen||CEO||Buy||5,682||$3.08||$17,500.56|| |
|5/15/2015||Jonathan P Foster||CFO||Buy||4,270||$3.07||$13,108.90|| |
|12/16/2014||Eric K Steen||CEO||Buy||15,100||$2.73||$41,223.00|| |
|12/4/2014||Eric K Steen||CEO||Buy||3,669||$2.65||$9,722.85|| |
|11/26/2014||Eric K Steen||CEO||Buy||10,000||$2.75||$27,500.00|| |
|11/17/2014||Eric K Steen||CEO||Buy||10,000||$2.69||$26,900.00|| |
|8/27/2014||Eric K Steen||CEO||Buy||15,000||$2.75||$41,250.00|| |
|8/18/2014||Eric K Steen||CEO||Buy||12,750||$2.79||$35,572.50|| |
|8/13/2014||Eric K Steen||CEO||Buy||7,262||$2.79||$20,260.98|| |
|8/11/2014||Eric K Steen||CEO||Buy||11,172||$2.71||$30,276.12|| |
|5/7/2014||Eric K Steen||CEO||Buy||10,000||$2.80||$28,000.00|| |
|3/17/2014||Ryan J Morris||Chairman||Sell||24,600||$2.90||$71,340.00|| |
|3/13/2014||Jonathan P Foster||CFO||Buy||5,000||$2.78||$13,900.00|| |
|8/14/2013||Eric K Steen||CEO||Buy||15,000||$1.42||$21,300.00|| |
Headline Trends for InfuSystem Holdings (NYSEAMERICAN:INFU)
Latest Headlines for InfuSystem Holdings (NYSEAMERICAN INFU)
InfuSystem Holdings (NYSEAMERICAN INFU) Chart for Saturday, November, 18, 2017